Cresco Labs Inc. announced that it has entered into a non-brokered credit agreement for a senior secured term loan in an initial aggregate principal amount of up to USD 100 million, with a mutual option to increase the size of the facility to a maximum of USD 200 million. The Company expects to complete an initial drawdown of up to USD 100 million on or about January 30, 2020, subject to the satisfaction of customary funding conditions. The proceeds from the Senior Loan will be used to fund the expansion of operations in Illinois, closing and integration costs associated with pending acquisitions, and other strategic growth initiatives in key markets.